Core technology underlying all three projects — MovAiD (personalized kineto-dynamics), An.Dy (human-robot collaboration), and CuraBone (bone regeneration modeling).
ANYBODY TECHNOLOGY AS
Danish SME providing musculoskeletal modeling software for assistive devices, human-robot collaboration, and biomechanical simulation.
Their core work
AnyBody Technology is a Danish SME that develops musculoskeletal modeling and simulation software — their core product, the AnyBody Modeling System, allows engineers and researchers to create detailed biomechanical models of the human body. In H2020 projects, they contributed their simulation expertise to design personalized assistive devices and advance human-robot collaboration. Their technology sits at the intersection of biomechanics, ergonomics, and computational modeling, enabling partners to predict how the human body interacts with products, robots, and medical treatments.
What they specialise in
MovAiD focused on manufacturing personalized movement-assisting devices; An.Dy on anticipatory behaviors in human-robot dyads.
An.Dy project specifically addressed anticipatory behaviors in dyadic human-robot collaboration.
CuraBone applied patient-specific multiscale modeling to predict bone regeneration outcomes.
How they've shifted over time
AnyBody Technology's H2020 involvement is concentrated in a narrow window (2015–2017 start dates), making evolution analysis limited. Their earliest project (MovAiD, 2015) focused on manufacturing personalized physical assistive devices, while their later projects (An.Dy and CuraBone, both 2017) shifted toward robotics interaction and predictive biomedical modeling. The trajectory suggests a move from passive assistive hardware toward intelligent, anticipatory systems and patient-specific simulation.
Moving from static biomechanical products toward dynamic human-robot systems and predictive patient-specific simulations — a partner likely interested in digital twins of human movement.
How they like to work
AnyBody Technology has never coordinated an H2020 project — they join as a specialist participant or third party, contributing their simulation software and biomechanical modeling expertise. With 28 unique partners across 11 countries from just 3 projects, they operate in large, diverse consortia rather than tight clusters. This profile suggests a reliable specialist contributor that enhances consortia with a specific, hard-to-replicate technical capability.
Despite only 3 projects, AnyBody Technology has built a broad network of 28 partners across 11 countries, reflecting participation in sizable international consortia. Their connections span manufacturing, robotics, and biomedical research communities across Europe.
What sets them apart
AnyBody Technology occupies a rare niche: they are one of very few companies worldwide offering commercial musculoskeletal simulation software capable of modeling full-body biomechanics. This makes them a uniquely valuable consortium partner whenever a project needs to understand how humans physically interact with devices, robots, or treatments. For consortium builders, they bring a ready-made, validated simulation platform rather than building models from scratch.
Highlights from their portfolio
- MovAiDLargest EC contribution (EUR 408,750) — combined biomechanical simulation with manufacturing of personalized assistive devices, bridging digital modeling and physical production.
- An.DyFocused on anticipatory human-robot collaboration, representing AnyBody's push into the robotics and AI-adjacent space beyond traditional biomechanics.
- CuraBoneParticipated as third party in a patient-specific bone regeneration project, demonstrating their simulation platform's applicability in medical/clinical contexts.